-Peter A Crooks Researcher Activity Profile

Research Author Detailed Information 

Peter A Crooks Publication Rate By Year

Peter A Crooks has published 1 paper(s) in 2005, 4 paper(s) in 2006, 32 paper(s) in 2007, 2 paper(s) in 2008, for a total of 39 research publications in total.

Peter A Pa Crooks Author Information

LAST NAME: crooks

FIRST NAME: Peter A

INITIALS: pa

AFFILIATION:

Papers

Peter A Crooks's Publication Record

1. (Z)-2-[(1-Phenylsulfonyl-1H-indol-3-yl)methylene]-1-azabicyclo[2.2.2]octan-3-one semicarbazone. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.
2. (E)-2-Methyl-3-(2-methyl-2-nitrovinyl)-1H-indole and (E)-3-(2-methyl-2-nitrovinyl)-2-phenyl-1H-indole. Year Published: 2005
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington KY 40536, USA.
3. 1-(1H-Indol-3-ylcarbonyl)-N-(4-methoxybenzyl)formamide. Year Published: 2006
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington KY 40536, USA.
4. Synthesis and hydrolytic behavior of two novel tripartate codrugs of naltrexone and 6beta-naltrexol with hydroxybupropion as potential alcohol abuse and smoking cessation agents. Year Published: 2006
College of Pharmacy, Department of Pharmaceutical Sciences, University of Kentucky, Lexington, KY 40536-0082, USA.
5. Effects of nornicotine enantiomers on intravenous S(-)-nicotine self-administration and cardiovascular function in rats. Year Published: 2006
Department of Psychology, University of Kentucky, BBSRB, Room 253, Lexington, KY 40536-0509, USA.
6. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions. Year Published: 2006
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 725 Rose Street, Lexington, KY 40536, USA.
7. Nornicotine inhibition of dopamine transporter function in striatum via nicotinic receptor activation. Year Published: 2007
Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky 40536, USA.
8. Vesicular monoamine transporter 2: role as a novel target for drug development. Year Published: 2007
College of Pharmacy, University of Kentucky, Department of Pharmaceutical Sciences, Lexington, KY 40536-0082, USA.
9. Novel chemical enhancers of heat shock increase thermal radiosensitization through a mitotic catastrophe pathway. Year Published: 2007
Department of Radiation Oncology/Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA, and Princess Margaret Hospital, Toronto, Ontario, Canada.
10. N, N -disubstituted piperazines and homopiperazines: synthesis and affinities at alpha4beta2* and alpha7* neuronal nicotinic acetylcholine receptors. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 725 Rose Street, Lexington, KY 40536-0082, USA.
11. (Z)-2-(1-Benzyl-5-nitro-1H-indol-3-ylmethylene)-1-azabicyclo[2.2.2]octan-3-one. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.
12. The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens. Year Published: 2007
Center for Drug Abuse Research Translation, University of Kentucky, Lexington, KY 40506, USA.
13. The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery. Year Published: 2007
Pharmacology and Therapeutics, University of Florida, College of Medicine, Gainesville, Florida 32610, USA. rlpapke@ufl.edu
14. (4-Methoxy-3-nitrobenzylideneamino)guanidinium chloride. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.
15. rac-(Z)-2-(2-Thienylmethylene)-1-azabicyclo[2.2.2]octan-3-ol. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.
16. Lobelane decreases methamphetamine self-administration in rats. Year Published: 2007
Department of Psychology, University of Kentucky, Lexington, KY 40536, USA.
17. A pharmacokinetic study on Z-(+/-)-2-(1-benzylindole-3-yl-methylene)azabicyclo[2.2.2]octane-3-ol; a novel radio-sensitization agent. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.
18. An HPLC method for the simultaneous determination of neurotoxic dipyridyl isomers in human plasma. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.
19. The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN. Year Published: 2007
Graduate Center for Toxicology, University of Kentucky, 800 Rose Street, Lexington, KY 40536, USA.
20. Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD). Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA. LDwoskin@email.uky.edu
21. Effect of celecoxib and novel agent LC-1 in a hamster model of lung cancer. Year Published: 2007
Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
22. tris-Azaaromatic quaternary ammonium salts: Novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.
23. Novel substituted (Z)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-one and (Z)-(+/-)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-ol derivatives as potent thermal sensitizing agents. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.
24. (E)-3-(Benzo[b]thiophen-2-yl)-2-(3,4,5-trimethoxyphenyl)acrylonitrile and (Z)-3-(benzo[b]thiophen-2-yl)-2-(3,4-dimethoxyphenyl)acrylonitrile. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.
25. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Year Published: 2007
26. (E)-3-(benzo[b]thiophen-2-yl)-2-(3,4,5-trimethoxyphenyl)acrylonitrile and (Z)-3-(benzo[b]thiophen-2-yl)-2-(3,4-dimethoxyphenyl)acrylonitrile. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.
27. Effect of celecoxib and novel agent LC-1 in a hamster model of lung cancer. Year Published: 2007
Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
28. Tris-azaaromatic quaternary ammonium salts: Novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.
29. Novel substituted (Z)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-one and (Z)-(+/-)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-ol derivatives as potent thermal sensitizing agents. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.
30. Carrier-mediated transport of the quaternary ammonium neuronal nicotinic receptor antagonist n,n'-dodecylbispicolinium dibromide at the blood-brain barrier. Year Published: 2007
Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, 1300 S. Coulter Dr., Amarillo, TX 79106-1712. paul.lockman@ttuhsc.edu.
31. Carrier-mediated transport of the quaternary ammonium neuronal nicotinic receptor antagonist n,n'-dodecylbispicolinium dibromide at the blood-brain barrier. Year Published: 2007
Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, 1300 S. Coulter Dr., Amarillo, TX 79106-1712, USA. paul.lockman@ttuhsc.edu
32. (E)-3-(benzo[b]thiophen-2-yl)-2-(3,4,5-trimethoxyphenyl)acrylonitrile and (Z)-3-(benzo[b]thiophen-2-yl)-2-(3,4-dimethoxyphenyl)acrylonitrile. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.
33. Tris-azaaromatic quaternary ammonium salts: Novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.
34. Novel substituted (Z)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-one and (Z)-(+/-)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-ol derivatives as potent thermal sensitizing agents. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.
35. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Year Published: 2007
James P Wilmot Cancer Center, University of Rochester, NY 14642, USA.
36. Carrier-mediated transport of the quaternary ammonium neuronal nicotinic receptor antagonist n,n'-dodecylbispicolinium dibromide at the blood-brain barrier. Year Published: 2007
Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, 1300 S. Coulter Dr., Amarillo, TX 79106-1712, USA. paul.lockman@ttuhsc.edu
37. Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo. Year Published: 2007
Department of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA. myipschn@iupui.edu
38. Bis-azaaromatic quaternary ammonium salts as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release: An investigation of binding conformation. Year Published: 2008
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.
39. Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo. Year Published: 2008
1Center for Drug Abuse Research Translation, University of Kentucky, Lexington, KY, USA.